Similar articles

• Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.

  He ZY, Wu SG, Zhou J, Li FY, Lin Q, Lin HX, Sun JY. He ZY, et al. PLoS One. 2015 Mar 17;10(3):e0119105. doi: 10.1371/journal.pone.0119105. eCollection 2015. PLoS One. 2015. PMID: 25781605 Free PMC article.
• Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapy.

  Huang CJ, Hou MF, Chuang HY, Lian SL, Huang MY, Chen FM, Fu OY, Lin SF. Huang CJ, et al. Jpn J Clin Oncol. 2012 Aug;42(8):711-20. doi: 10.1093/jjco/hys080. Epub 2012 May 29. Jpn J Clin Oncol. 2012. PMID: 22645150
• Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

  Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E. Truong PT, et al. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47. doi: 10.1016/j.ijrobp.2004.08.009. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817335
• Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy.

  Truong PT, Woodward WA, Buchholz TA. Truong PT, et al. Expert Rev Anticancer Ther. 2006 Feb;6(2):205-16. doi: 10.1586/14737140.6.2.205. Expert Rev Anticancer Ther. 2006. PMID: 16445373 Review.
• Mounting evidence for postmastectomy locoregional radiation therapy.

  Marks LB, Hardenbergh P, Prosnitz LR. Marks LB, et al. Oncology (Williston Park). 1999 Aug;13(8):1123-35; discussion 1135-42, 1144. Oncology (Williston Park). 1999. PMID: 10499246 Review.